annual D&A:
$78.78M+$3.21M(+4.25%)Summary
- As of today (September 17, 2025), PCRX annual depreciation & amortization is $78.78 million, with the most recent change of +$3.21 million (+4.25%) on December 31, 2024.
- During the last 3 years, PCRX annual D&A has risen by +$50.24 million (+175.97%).
- PCRX annual D&A is now -13.90% below its all-time high of $91.50 million, reached on December 31, 2022.
Performance
PCRX Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$27.32M+$6.15M(+29.07%)Summary
- As of today (September 17, 2025), PCRX quarterly depreciation & amortization is $27.32 million, with the most recent change of +$6.15 million (+29.07%) on June 30, 2025.
- Over the past year, PCRX quarterly D&A has increased by +$8.46 million (+44.84%).
- PCRX quarterly D&A is now -10.14% below its all-time high of $30.41 million, reached on December 31, 2022.
Performance
PCRX quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$89.99M+$8.46M(+10.38%)Summary
- As of today (September 17, 2025), PCRX TTM depreciation & amortization is $89.99 million, with the most recent change of +$8.46 million (+10.38%) on June 30, 2025.
- Over the past year, PCRX TTM D&A has increased by +$15.78 million (+21.26%).
- PCRX TTM D&A is now -1.66% below its all-time high of $91.50 million, reached on December 31, 2022.
Performance
PCRX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
PCRX Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +4.3% | +44.8% | +21.3% |
| 3 y3 years | +176.0% | +30.9% | +50.7% |
| 5 y5 years | +302.5% | +447.6% | +338.9% |
PCRX Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -13.9% | +176.0% | -10.1% | +48.3% | -1.7% | +50.7% |
| 5 y | 5-year | -13.9% | +302.5% | -10.1% | +463.2% | -1.7% | +353.4% |
| alltime | all time | -13.9% | +2394.0% | -10.1% | +2799.8% | -1.7% | >+9999.0% |
PCRX Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $27.32M(+29.1%) | $89.99M(+10.4%) |
| Mar 2025 | - | $21.17M(-0.4%) | $81.53M(+3.5%) |
| Dec 2024 | $78.78M(+4.2%) | $21.24M(+4.9%) | $78.78M(+3.6%) |
| Sep 2024 | - | $20.25M(+7.4%) | $76.03M(+2.5%) |
| Jun 2024 | - | $18.86M(+2.4%) | $74.21M(-0.3%) |
| Mar 2024 | - | $18.43M(-0.3%) | $74.40M(-1.6%) |
| Dec 2023 | $75.57M(-17.4%) | $18.48M(+0.3%) | $75.57M(-13.6%) |
| Sep 2023 | - | $18.43M(-3.3%) | $87.50M(-2.0%) |
| Jun 2023 | - | $19.05M(-2.8%) | $89.26M(-2.0%) |
| Mar 2023 | - | $19.60M(-35.5%) | $91.07M(-0.5%) |
| Dec 2022 | $91.50M(+220.5%) | $30.41M(+50.5%) | $91.50M(+23.4%) |
| Sep 2022 | - | $20.20M(-3.2%) | $74.17M(+24.2%) |
| Jun 2022 | - | $20.86M(+4.1%) | $59.70M(+36.5%) |
| Mar 2022 | - | $20.03M(+53.3%) | $43.73M(+53.2%) |
| Dec 2021 | $28.55M(+43.4%) | $13.07M(+128.1%) | $28.55M(+39.0%) |
| Sep 2021 | - | $5.73M(+17.0%) | $20.54M(+3.5%) |
| Jun 2021 | - | $4.90M(+0.9%) | $19.85M(-0.5%) |
| Mar 2021 | - | $4.85M(-4.1%) | $19.94M(+0.2%) |
| Dec 2020 | $19.91M(+1.7%) | $5.06M(+0.5%) | $19.91M(-0.1%) |
| Sep 2020 | - | $5.04M(+1.0%) | $19.94M(-2.8%) |
| Jun 2020 | - | $4.99M(+3.5%) | $20.50M(-1.4%) |
| Mar 2020 | - | $4.82M(-5.3%) | $20.80M(+6.2%) |
| Dec 2019 | $19.58M(+48.7%) | $5.09M(-9.2%) | $19.58M(+5.6%) |
| Sep 2019 | - | $5.61M(+6.1%) | $18.54M(+12.8%) |
| Jun 2019 | - | $5.28M(+46.7%) | $16.44M(+17.4%) |
| Mar 2019 | - | $3.60M(-11.1%) | $14.00M(+6.4%) |
| Dec 2018 | $13.16M(-4.8%) | $4.05M(+15.6%) | $13.16M(+3.1%) |
| Sep 2018 | - | $3.50M(+23.0%) | $12.77M(+1.1%) |
| Jun 2018 | - | $2.85M(+3.1%) | $12.63M(-6.4%) |
| Mar 2018 | - | $2.76M(-24.5%) | $13.49M(-2.5%) |
| Dec 2017 | $13.83M | $3.66M(+8.9%) | $13.83M(+3.0%) |
| Sep 2017 | - | $3.36M(-9.4%) | $13.43M(+0.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2017 | - | $3.71M(+19.5%) | $13.35M(+3.8%) |
| Mar 2017 | - | $3.10M(-4.8%) | $12.86M(-0.5%) |
| Dec 2016 | $12.92M(+12.6%) | $3.26M(-0.5%) | $12.92M(+1.1%) |
| Sep 2016 | - | $3.28M(+1.9%) | $12.78M(+3.6%) |
| Jun 2016 | - | $3.22M(+1.6%) | $12.33M(+3.6%) |
| Mar 2016 | - | $3.17M(+1.5%) | $11.90M(+3.7%) |
| Dec 2015 | $11.47M(+14.3%) | $3.12M(+10.2%) | $11.47M(+3.7%) |
| Sep 2015 | - | $2.83M(+1.7%) | $11.06M(+4.1%) |
| Jun 2015 | - | $2.78M(+1.5%) | $10.63M(+4.4%) |
| Mar 2015 | - | $2.74M(+1.3%) | $10.18M(+1.4%) |
| Dec 2014 | $10.04M(+74.6%) | $2.71M(+13.2%) | $10.04M(+11.2%) |
| Sep 2014 | - | $2.39M(+2.5%) | $9.03M(+13.3%) |
| Jun 2014 | - | $2.33M(-10.4%) | $7.97M(+15.1%) |
| Mar 2014 | - | $2.60M(+53.1%) | $6.92M(+20.4%) |
| Dec 2013 | $5.75M(+1.8%) | $1.70M(+27.8%) | $5.75M(+4.6%) |
| Sep 2013 | - | $1.33M(+3.4%) | $5.49M(-1.6%) |
| Jun 2013 | - | $1.29M(-10.1%) | $5.58M(-2.1%) |
| Mar 2013 | - | $1.43M(-1.0%) | $5.70M(+0.9%) |
| Dec 2012 | $5.65M(+30.9%) | $1.45M(+2.0%) | $5.65M(+3.0%) |
| Sep 2012 | - | $1.42M(+0.9%) | $5.49M(+7.6%) |
| Jun 2012 | - | $1.41M(+1.8%) | $5.10M(+8.4%) |
| Mar 2012 | - | $1.38M(+7.5%) | $4.70M(+9.0%) |
| Dec 2011 | $4.31M(+6.0%) | $1.28M(+24.8%) | $4.31M(+6.9%) |
| Sep 2011 | - | $1.03M(+1.8%) | $4.04M(-33.5%) |
| Jun 2011 | - | $1.01M(+2.1%) | $6.07M(+50.0%) |
| Mar 2011 | - | $990.00K(-1.5%) | $4.05M(-0.5%) |
| Dec 2010 | $4.07M(-1.8%) | $1.00M(-67.2%) | $4.07M(+32.8%) |
| Sep 2010 | - | $3.07M(-403.0%) | $3.07M(>+9900.0%) |
| Jun 2010 | - | -$1.01M(-200.0%) | $0.00(-100.0%) |
| Mar 2010 | - | $1.01M | $1.01M |
| Dec 2009 | $4.15M(-1.9%) | - | - |
| Dec 2008 | $4.23M(+33.8%) | - | - |
| Dec 2007 | $3.16M | - | - |
FAQ
- What is Pacira BioSciences, Inc. annual depreciation & amortization?
- What is the all time high annual D&A for Pacira BioSciences, Inc.?
- What is Pacira BioSciences, Inc. annual D&A year-on-year change?
- What is Pacira BioSciences, Inc. quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Pacira BioSciences, Inc.?
- What is Pacira BioSciences, Inc. quarterly D&A year-on-year change?
- What is Pacira BioSciences, Inc. TTM depreciation & amortization?
- What is the all time high TTM D&A for Pacira BioSciences, Inc.?
- What is Pacira BioSciences, Inc. TTM D&A year-on-year change?
What is Pacira BioSciences, Inc. annual depreciation & amortization?
The current annual D&A of PCRX is $78.78M
What is the all time high annual D&A for Pacira BioSciences, Inc.?
Pacira BioSciences, Inc. all-time high annual depreciation & amortization is $91.50M
What is Pacira BioSciences, Inc. annual D&A year-on-year change?
Over the past year, PCRX annual depreciation & amortization has changed by +$3.21M (+4.25%)
What is Pacira BioSciences, Inc. quarterly depreciation & amortization?
The current quarterly D&A of PCRX is $27.32M
What is the all time high quarterly D&A for Pacira BioSciences, Inc.?
Pacira BioSciences, Inc. all-time high quarterly depreciation & amortization is $30.41M
What is Pacira BioSciences, Inc. quarterly D&A year-on-year change?
Over the past year, PCRX quarterly depreciation & amortization has changed by +$8.46M (+44.84%)
What is Pacira BioSciences, Inc. TTM depreciation & amortization?
The current TTM D&A of PCRX is $89.99M
What is the all time high TTM D&A for Pacira BioSciences, Inc.?
Pacira BioSciences, Inc. all-time high TTM depreciation & amortization is $91.50M
What is Pacira BioSciences, Inc. TTM D&A year-on-year change?
Over the past year, PCRX TTM depreciation & amortization has changed by +$15.78M (+21.26%)